HOME >> MEDICINE >> NEWS
Higher doses of cancer drug imatinib proven effective and safe

ortance as previous studies of another cancer drug (interferon alpha) have shown that CCR is associated with a 70 to 80 percent chance of 10-year survival, a positive prospect as the survival time for newly diagnosed CML patients is typically about five years.

Another measure of successful treatment is the number of patients with complete molecular response, occurring when the levels of BCR-ABL are so low that they are undetectable using a highly sensitive method called polymerase chain reaction. In past studies, patients who had undetectable levels of BCR-ABL after treatment have not relapsed after long-term follow up. In high-dose therapy patients, the incidence of complete molecular response was 28 percent compared to only seven percent of patients taking the standard dosage of imatinib.

"The high rates of complete cytogenetic and molecular response that we've seen in this study are unprecedented. If such responses have similar long-term significance as seen in previous studies, this translates into a major improvement in the prognosis of patients with CML," states Hagop Kantarjian, M.D., chairman of the Department of Leukemia at M. D. Anderson Cancer Center and the lead author of the study.

Researchers found that the high dosage of imatinib was generally well tolerated, with a similar rate of side effects as standard dose imatinib. To reduce more severe side effects, the dosage of imatinib was lowered to 600 mg or 400 mg daily for some patients, though a majority remained at the target dosage.

The disease did not transform beyond the chronic phrase in any of the study patients, and 98 percent had a complete hematologic response, meaning the number of white blood cells was no longer out of control and the signs and symptoms of leukemia were gone.

The results of the study indicate that patients in the early stage of this cancer may benefit from higher doses of the drug imatinib in their initial treatment to safely and effe
'"/>

Contact: Aislinn Raedy
araedy@hematology.org
202-776-0544
American Society of Hematology
1-Apr-2004


Page: 1 2 3

Related medicine news :

1. Higher folate intake associated with decreased risk of hypertension in women
2. Higher incidence of rejection following early steroid withdrawal
3. Higher radiation doses help some lung cancer patients live longer
4. Higher dose of Gleevec leads to increased remission in CML patients
5. Higher education or larger brain size may protect against dementia later in life, new study finds
6. Higher cost sharing reduces plans drug expenditures, but boosts enrollee costs
7. Higher nocturnal blood pressure predictive of kidney disease in diabetes
8. First quarter 2002 prescription drug spending: Higher again, but rate of increase drops
9. Higher rate of improvement, lower rate of adverse effects with clarithromycin for acute exacerbations of chronic bronchitis
10. Cancer Rates In Children Of Nuclear Industry Employees No Higher Than General Population In England And Wales
11. New Study Finds Blacks Face 38 Percent Higher Stroke Risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2016)... ... February 14, 2016 , ... With ProCel Parallax users now have the ability ... With ProCel Parallax each user has total control over angle of view, layer position, ... infinite possibilities. ProCel Parallax offers in and out animation, custom camera animations, text animations, ...
(Date:2/14/2016)... ... February 14, 2016 , ... Many eating disorder patients complete ... residence. The nature of the illnesses requires ongoing supervision, therapy and support. There ... work to make traditional appointments. These people struggle to maintain recovery or to ...
(Date:2/14/2016)... ... February 14, 2016 , ... ... Association of Heart Failure Nurses (AAHFN) is promoting healthier living with heart failure ... Spices of Life! Healthy Living with Heart Failure will kick-off February 14 and ...
(Date:2/13/2016)... ... February 13, 2016 , ... Good news for ... in the area to offer AngioPlex™ Optical Coherence Tomography (OCT) Angiography, imaging technology ... macular degeneration, diabetic retinopathy, and other vascular conditions. , In just a few ...
(Date:2/13/2016)... ... ... in Sun City is the place to be on March 3rd to learn about the ... be hosting this educational seminar from 5:30 p.m. – 7:00 p.m. Exciting advancements will be ... In addition, prizes will be given away and light refreshments will be served. , ...
Breaking Medicine News(10 mins):
(Date:2/14/2016)... 14, 2016  Ennaid Therapeutics, located in ... help the millions of people worldwide when infected with the ... health emergency by the World Health Organization and the ... care in response to Zika,s explosive spread and is calling ... therapeutics and vaccines for those who contract it. ...
(Date:2/12/2016)... N.C. , Feb. 12, 2016  Clinical Affairs leaders at ... presence in emerging areas of the world. While some companies have ... lag in their clinical activity in countries such as ... China and India ... market products in those countries. --> China ...
(Date:2/12/2016)... Va. , Feb. 12, 2016   National ... Hoey , RPh, MBA issued the following statement today ... released by the Centers for Medicare & ... raised by NCPA, beneficiary advocates and others: ... raised. We are still reviewing the full CMS analysis. ...
Breaking Medicine Technology:
Cached News: